Microbiology FDA 483 (Eugia Pharma Specialities): Procedures to prevent microbiological contamination did not include adequate validation of the aseptic process
In commercial production, sterile *** API is aseptically filled into canisters, approximately *** batch. *** filling, *** canister is opened